Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-14)

In this article we will discuss Durvalumab (Warnings-14)

In this article, we will discuss Durvalumab (Warnings-14). So, let’s get started.

  • Immune-Mediated Endocrinopathies Adrenal Insufficiency
  • Durvalumab can cause primary or secondary adrenal insufficiency. For Grade 2 or higher adrenal insufficiency, initiate symptomatic treatment, including hormone replacement as clinically indicated. Withhold or permanently discontinue Durvalumab based on the severity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.